Fifth Circuit Revives Bid to Block Medicare Drug Price Negotiation Program
- September 27, 2024
The Fifth Circuit reversed September 20 the dismissal of the National Infusion Cancer Association’s (NICA’s) constitutional challenge to the Medicare drug price negotiation program after finding the group’s claims did not “arise under” the Medicare Act.
ARTICLE TAGS
You must be logged in to access this content.